Listed

Krystal Biotech, Inc.

KRYSNasdaqCIK 1711279HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$119.2m, Q2 FY2026
Operating income$58.4m, Q2 FY2026
Net income$54.8m, Q2 FY2026
Krystal Biotech, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m8.6Revenue, Q3 FY2023, three months to 2023-09-30$8.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-04, accession 0001711279-24-000056.Report this figure42.1Revenue, Q4 FY2023, three months to 2023-12-31$42.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure45.3Revenue, Q1 FY2024, three months to 2024-03-31$45.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-06, accession 0001711279-25-000044.Report this figure70.3Revenue, Q2 FY2024, three months to 2024-06-30$70.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-04, accession 0001711279-25-000077.Report this figure83.8Revenue, Q3 FY2024, three months to 2024-09-30$83.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure91.1Revenue, Q4 FY2024, three months to 2024-12-31$91.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure88.2Revenue, Q1 FY2025, three months to 2025-03-31$88.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure96.0Revenue, Q2 FY2025, three months to 2025-06-30$96.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure97.8Revenue, Q3 FY2025, three months to 2025-09-30$97.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure107Revenue, Q4 FY2025, three months to 2025-12-31$107.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure116Revenue, Q1 FY2026, three months to 2026-03-31$116.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure119Revenue, Q2 FY2026, three months to 2026-06-30$119.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure
Research and development$m10.6Research and development, Q3 FY2023, three months to 2023-09-30$10.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-04, accession 0001711279-24-000056.Report this figure11.4Research and development, Q4 FY2023, three months to 2023-12-31$11.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure11.0Research and development, Q1 FY2024, three months to 2024-03-31$11.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-06, accession 0001711279-25-000044.Report this figure15.6Research and development, Q2 FY2024, three months to 2024-06-30$15.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-04, accession 0001711279-25-000077.Report this figure13.5Research and development, Q3 FY2024, three months to 2024-09-30$13.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure13.5Research and development, Q4 FY2024, three months to 2024-12-31$13.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure14.3Research and development, Q1 FY2025, three months to 2025-03-31$14.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure14.4Research and development, Q2 FY2025, three months to 2025-06-30$14.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure14.6Research and development, Q3 FY2025, three months to 2025-09-30$14.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure14.8Research and development, Q4 FY2025, three months to 2025-12-31$14.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure15.3Research and development, Q1 FY2026, three months to 2026-03-31$15.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure14.5Research and development, Q2 FY2026, three months to 2026-06-30$14.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure
Selling, general and administrative$m23.7Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$23.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-04, accession 0001711279-24-000056.Report this figure24.7Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$24.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure26.1Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$26.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-06, accession 0001711279-25-000044.Report this figure27.6Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$27.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-04, accession 0001711279-25-000077.Report this figure28.7Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$28.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure31.3Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$31.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure32.6Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$32.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure35.1Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$35.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure37.6Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$37.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure41.4Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$41.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure41.0Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$41.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure39.9Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$39.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure
Operating income$m(26.0)Operating income, Q3 FY2023, three months to 2023-09-30−$26.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-04, accession 0001711279-24-000056.Report this figure3.2Operating income, Q4 FY2023, three months to 2023-12-31$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure(6.7)Operating income, Q1 FY2024, three months to 2024-03-31−$6.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0001711279-25-000044.Report this figure8.6Operating income, Q2 FY2024, three months to 2024-06-30$8.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-04, accession 0001711279-25-000077.Report this figure22.5Operating income, Q3 FY2024, three months to 2024-09-30$22.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure41.4Operating income, Q4 FY2024, three months to 2024-12-31$41.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure36.3Operating income, Q1 FY2025, three months to 2025-03-31$36.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure39.4Operating income, Q2 FY2025, three months to 2025-06-30$39.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure41.4Operating income, Q3 FY2025, three months to 2025-09-30$41.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure44.3Operating income, Q4 FY2025, three months to 2025-12-31$44.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure53.7Operating income, Q1 FY2026, three months to 2026-03-31$53.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure58.4Operating income, Q2 FY2026, three months to 2026-06-30$58.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-04, accession 0001711279-24-000056.Report this figure2.0Income tax, Q4 FY2023, three months to 2023-12-31$2.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-06, accession 0001711279-25-000044.Report this figure0.5Income tax, Q2 FY2024, three months to 2024-06-30$477.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-04, accession 0001711279-25-000077.Report this figure2.6Income tax, Q3 FY2024, three months to 2024-09-30$2.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure3.1Income tax, Q4 FY2024, three months to 2024-12-31$3.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure7.9Income tax, Q1 FY2025, three months to 2025-03-31$7.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure8.4Income tax, Q2 FY2025, three months to 2025-06-30$8.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure(31.4)Income tax, Q3 FY2025, three months to 2025-09-30−$31.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure(0.3)Income tax, Q4 FY2025, three months to 2025-12-31−$269.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure5.5Income tax, Q1 FY2026, three months to 2026-03-31$5.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure11.3Income tax, Q2 FY2026, three months to 2026-06-30$11.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure
Net income$m80.7Net income, Q3 FY2023, three months to 2023-09-30$80.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-04, accession 0001711279-24-000056.Report this figure8.7Net income, Q4 FY2023, three months to 2023-12-31$8.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure0.9Net income, Q1 FY2024, three months to 2024-03-31$932.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure15.6Net income, Q2 FY2024, three months to 2024-06-30$15.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure27.2Net income, Q3 FY2024, three months to 2024-09-30$27.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure45.5Net income, Q4 FY2024, three months to 2024-12-31$45.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure35.7Net income, Q1 FY2025, three months to 2025-03-31$35.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure38.3Net income, Q2 FY2025, three months to 2025-06-30$38.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure79.4Net income, Q3 FY2025, three months to 2025-09-30$79.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure51.4Net income, Q4 FY2025, three months to 2025-12-31$51.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure55.9Net income, Q1 FY2026, three months to 2026-03-31$55.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure54.8Net income, Q2 FY2026, three months to 2026-06-30$54.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure
Diluted EPS$ per share2.79Diluted EPS, Q3 FY2023, three months to 2023-09-30$2.79 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-04, accession 0001711279-24-000056.Report this figurenot reported0.03Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0001711279-25-000044.Report this figure0.53Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-04, accession 0001711279-25-000077.Report this figure0.91Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.91 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figurenot reported1.20Diluted EPS, Q1 FY2025, three months to 2025-03-31$1.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure1.29Diluted EPS, Q2 FY2025, three months to 2025-06-30$1.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure2.66Diluted EPS, Q3 FY2025, three months to 2025-09-30$2.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figurenot reported1.83Diluted EPS, Q1 FY2026, three months to 2026-03-31$1.83 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure1.79Diluted EPS, Q2 FY2026, three months to 2026-06-30$1.79 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure
Basic EPS$ per share2.88Basic EPS, Q3 FY2023, three months to 2023-09-30$2.88 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-04, accession 0001711279-24-000056.Report this figurenot reported0.03Basic EPS, Q1 FY2024, three months to 2024-03-31$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0001711279-25-000044.Report this figure0.54Basic EPS, Q2 FY2024, three months to 2024-06-30$0.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-04, accession 0001711279-25-000077.Report this figure0.95Basic EPS, Q3 FY2024, three months to 2024-09-30$0.95 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figurenot reported1.24Basic EPS, Q1 FY2025, three months to 2025-03-31$1.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure1.33Basic EPS, Q2 FY2025, three months to 2025-06-30$1.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure2.74Basic EPS, Q3 FY2025, three months to 2025-09-30$2.74 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figurenot reported1.91Basic EPS, Q1 FY2026, three months to 2026-03-31$1.91 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure1.85Basic EPS, Q2 FY2026, three months to 2026-06-30$1.85 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure

Balance sheet

Cash and equivalents$427.7m, Q2 FY2026
Shareholders' equity$1.36bn, Q2 FY2026
Krystal Biotech, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m373Cash and equivalents, Q3 FY2023, at 2023-09-30$373.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-06, accession 0001711279-23-000073.Report this figure358Cash and equivalents, FY2023, at 2023-12-31$358.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-19, accession 0001711279-25-000008.Report this figure359Cash and equivalents, Q1 FY2024, at 2024-03-31$359.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-06, accession 0001711279-24-000020.Report this figure346Cash and equivalents, Q2 FY2024, at 2024-06-30$345.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-05, accession 0001711279-24-000040.Report this figure374Cash and equivalents, Q3 FY2024, at 2024-09-30$374.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-04, accession 0001711279-24-000056.Report this figure345Cash and equivalents, FY2024, at 2024-12-31$344.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-17, accession 0001711279-26-000016.Report this figure309Cash and equivalents, Q1 FY2025, at 2025-03-31$308.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0001711279-25-000044.Report this figure354Cash and equivalents, Q2 FY2025, at 2025-06-30$353.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-04, accession 0001711279-25-000077.Report this figure393Cash and equivalents, Q3 FY2025, at 2025-09-30$392.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure496Cash and equivalents, FY2025, at 2025-12-31$496.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure501Cash and equivalents, Q1 FY2026, at 2026-03-31$501.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure428Cash and equivalents, Q2 FY2026, at 2026-06-30$427.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure
Current assets$m582Current assets, Q3 FY2023, at 2023-09-30$582.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-06, accession 0001711279-23-000073.Report this figure588Current assets, FY2023, at 2023-12-31$587.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-19, accession 0001711279-25-000008.Report this figure602Current assets, Q1 FY2024, at 2024-03-31$602.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-06, accession 0001711279-24-000020.Report this figure683Current assets, Q2 FY2024, at 2024-06-30$682.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-05, accession 0001711279-24-000040.Report this figure713Current assets, Q3 FY2024, at 2024-09-30$713.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-04, accession 0001711279-24-000056.Report this figure742Current assets, FY2024, at 2024-12-31$742.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-17, accession 0001711279-26-000016.Report this figure767Current assets, Q1 FY2025, at 2025-03-31$766.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0001711279-25-000044.Report this figure841Current assets, Q2 FY2025, at 2025-06-30$841.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-04, accession 0001711279-25-000077.Report this figure926Current assets, Q3 FY2025, at 2025-09-30$925.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure1,025Current assets, FY2025, at 2025-12-31$1.02bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure1,020Current assets, Q1 FY2026, at 2026-03-31$1.02bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure1,060Current assets, Q2 FY2026, at 2026-06-30$1.06bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure
Total assets$m790Total assets, Q3 FY2023, at 2023-09-30$790.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-06, accession 0001711279-23-000073.Report this figure818Total assets, FY2023, at 2023-12-31$818.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-19, accession 0001711279-25-000008.Report this figure853Total assets, Q1 FY2024, at 2024-03-31$853.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-06, accession 0001711279-24-000020.Report this figure918Total assets, Q2 FY2024, at 2024-06-30$917.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-05, accession 0001711279-24-000040.Report this figure982Total assets, Q3 FY2024, at 2024-09-30$982.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-04, accession 0001711279-24-000056.Report this figure1,056Total assets, FY2024, at 2024-12-31$1.06bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-17, accession 0001711279-26-000016.Report this figure1,074Total assets, Q1 FY2025, at 2025-03-31$1.07bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0001711279-25-000044.Report this figure1,138Total assets, Q2 FY2025, at 2025-06-30$1.14bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-04, accession 0001711279-25-000077.Report this figure1,240Total assets, Q3 FY2025, at 2025-09-30$1.24bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure1,334Total assets, FY2025, at 2025-12-31$1.33bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure1,397Total assets, Q1 FY2026, at 2026-03-31$1.40bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure1,501Total assets, Q2 FY2026, at 2026-06-30$1.50bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure
Current liabilities$m27.6Current liabilities, Q3 FY2023, at 2023-09-30$27.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-06, accession 0001711279-23-000073.Report this figure33.1Current liabilities, FY2023, at 2023-12-31$33.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-19, accession 0001711279-25-000008.Report this figure47.6Current liabilities, Q1 FY2024, at 2024-03-31$47.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-06, accession 0001711279-24-000020.Report this figure71.9Current liabilities, Q2 FY2024, at 2024-06-30$71.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-05, accession 0001711279-24-000040.Report this figure89.5Current liabilities, Q3 FY2024, at 2024-09-30$89.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-04, accession 0001711279-24-000056.Report this figure102Current liabilities, FY2024, at 2024-12-31$102.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-17, accession 0001711279-26-000016.Report this figure79.5Current liabilities, Q1 FY2025, at 2025-03-31$79.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0001711279-25-000044.Report this figure86.9Current liabilities, Q2 FY2025, at 2025-06-30$86.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-04, accession 0001711279-25-000077.Report this figure91.3Current liabilities, Q3 FY2025, at 2025-09-30$91.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure103Current liabilities, FY2025, at 2025-12-31$102.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure108Current liabilities, Q1 FY2026, at 2026-03-31$107.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure127Current liabilities, Q2 FY2026, at 2026-06-30$127.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure
Total liabilities$m34.4Total liabilities, Q3 FY2023, at 2023-09-30$34.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-06, accession 0001711279-23-000073.Report this figure39.7Total liabilities, FY2023, at 2023-12-31$39.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-19, accession 0001711279-25-000008.Report this figure54.1Total liabilities, Q1 FY2024, at 2024-03-31$54.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-06, accession 0001711279-24-000020.Report this figure78.8Total liabilities, Q2 FY2024, at 2024-06-30$78.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-05, accession 0001711279-24-000040.Report this figure96.5Total liabilities, Q3 FY2024, at 2024-09-30$96.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-04, accession 0001711279-24-000056.Report this figure109Total liabilities, FY2024, at 2024-12-31$109.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-17, accession 0001711279-26-000016.Report this figure89.7Total liabilities, Q1 FY2025, at 2025-03-31$89.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0001711279-25-000044.Report this figure97.7Total liabilities, Q2 FY2025, at 2025-06-30$97.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-04, accession 0001711279-25-000077.Report this figure102Total liabilities, Q3 FY2025, at 2025-09-30$102.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure114Total liabilities, FY2025, at 2025-12-31$114.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure120Total liabilities, Q1 FY2026, at 2026-03-31$120.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure142Total liabilities, Q2 FY2026, at 2026-06-30$141.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m756Shareholders' equity, Q3 FY2023, at 2023-09-30$755.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-04, accession 0001711279-24-000056.Report this figure779Shareholders' equity, FY2023, at 2023-12-31$778.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-17, accession 0001711279-26-000016.Report this figure799Shareholders' equity, Q1 FY2024, at 2024-03-31$799.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure839Shareholders' equity, Q2 FY2024, at 2024-06-30$838.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure886Shareholders' equity, Q3 FY2024, at 2024-09-30$885.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure946Shareholders' equity, FY2024, at 2024-12-31$946.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure985Shareholders' equity, Q1 FY2025, at 2025-03-31$984.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure1,041Shareholders' equity, Q2 FY2025, at 2025-06-30$1.04bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure1,138Shareholders' equity, Q3 FY2025, at 2025-09-30$1.14bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure1,220Shareholders' equity, FY2025, at 2025-12-31$1.22bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure1,277Shareholders' equity, Q1 FY2026, at 2026-03-31$1.28bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure1,359Shareholders' equity, Q2 FY2026, at 2026-06-30$1.36bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure

Cash flow

Operating cash flow$74.8m, Q2 FY2026
Capital expenditure$3.6m, Q2 FY2026
Krystal Biotech, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(21.2)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$21.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-04, accession 0001711279-24-000056. Derived: 9-month figure less the 6-month figure.Report this figure(7.2)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure15.9Operating cash flow, Q1 FY2024, three months to 2024-03-31$15.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0001711279-25-000044.Report this figure(4.2)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$4.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-04, accession 0001711279-25-000077. Derived: 6-month figure less the 3-month figure.Report this figure58.9Operating cash flow, Q3 FY2024, three months to 2024-09-30$58.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001711279-25-000087. Derived: 9-month figure less the 6-month figure.Report this figure52.8Operating cash flow, Q4 FY2024, three months to 2024-12-31$52.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure31.0Operating cash flow, Q1 FY2025, three months to 2025-03-31$31.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure52.7Operating cash flow, Q2 FY2025, three months to 2025-06-30$52.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001711279-26-000057. Derived: 6-month figure less the 3-month figure.Report this figure39.7Operating cash flow, Q3 FY2025, three months to 2025-09-30$39.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001711279-25-000087. Derived: 9-month figure less the 6-month figure.Report this figure77.5Operating cash flow, Q4 FY2025, three months to 2025-12-31$77.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure80.4Operating cash flow, Q1 FY2026, three months to 2026-03-31$80.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure74.8Operating cash flow, Q2 FY2026, three months to 2026-06-30$74.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001711279-26-000057. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m1.8Capital expenditure, Q3 FY2023, three months to 2023-09-30$1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-04, accession 0001711279-24-000056. Derived: 9-month figure less the 6-month figure.Report this figure1.8Capital expenditure, Q4 FY2023, three months to 2023-12-31$1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure1.3Capital expenditure, Q1 FY2024, three months to 2024-03-31$1.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-06, accession 0001711279-25-000044.Report this figure1.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-04, accession 0001711279-25-000077. Derived: 6-month figure less the 3-month figure.Report this figure1.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-03, accession 0001711279-25-000087. Derived: 9-month figure less the 6-month figure.Report this figure0.8Capital expenditure, Q4 FY2024, three months to 2024-12-31$801.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure6.2Capital expenditure, Q1 FY2025, three months to 2025-03-31$6.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure1.9Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0001711279-26-000057. Derived: 6-month figure less the 3-month figure.Report this figure1.7Capital expenditure, Q3 FY2025, three months to 2025-09-30$1.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-03, accession 0001711279-25-000087. Derived: 9-month figure less the 6-month figure.Report this figure2.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$2.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0001711279-26-000016. Derived: 12-month figure less the 9-month figure.Report this figure7.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$7.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure3.6Capital expenditure, Q2 FY2026, three months to 2026-06-30$3.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0001711279-26-000057. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)30.66m, Q2 FY2026
Krystal Biotech, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q1 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares25.6Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3025,619,125 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-06, accession 0001711279-23-000073.Report this figure25.7Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3125,712,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-06, accession 0001711279-24-000020.Report this figure26.7Diluted shares (weighted), Q1 FY2023, three months to 2023-06-3026,657,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-05, accession 0001711279-24-000040.Report this figure28.9Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3028,892,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-04, accession 0001711279-24-000056.Report this figure29.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3129,291,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0001711279-25-000044.Report this figure29.6Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3029,637,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-04, accession 0001711279-25-000077.Report this figure29.9Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3029,902,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure29.9Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3129,871,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure29.7Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3029,749,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure29.8Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3029,833,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0001711279-25-000087.Report this figure30.5Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3130,507,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-04, accession 0001711279-26-000043.Report this figure30.7Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3030,657,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure

Shares outstanding: 29.60mShares outstanding, period not labelled, at 2026-07-2829,598,836 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-03, accession 0001711279-26-000057.Report this figure at Jul 28, 2026, from the cover of the 10-Q filed Aug 3, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.